Association of Serum 25-Hydroxyvitamin D with Lifestyle Factors and Metabolic and Cardiovascular Disease Markers: Population-Based Cross-Sectional Study (FIN-D2D)

Objectives Low serum 25-hydroxyvitamin D (25OHD) level has been associated with an increased risk of several chronic diseases. Our aim was to determine lifestyle and clinical factors that are associated with 25OHD level and to investigate connection of 25OHD level with metabolic and cardiovascular disease markers. Design In total, 2868 Finnish men and women aged 45–74 years participated in FIN-D2D population-based health survey in 2007. Participants that had a serum sample available (98.4%; n = 2822) were included in this study. 25OHD was measured with chemiluminescent microparticle immunoassay method. Results The mean 25OHD level was 58.2 nmol/l in men (n = 1348) and 57.1 nmol/l in women (n = 1474). Mean 25OHD level was lower in the younger age groups than in the older ones (p<0.0001 both in men and women). This study confirmed that low physical activity (p<0.0001 both in men and women), smoking (p = 0.0002 in men and p = 0.03 in women) and high BMI (p<0.0001 in women) are factors that independently associate with low 25OHD level. Of the metabolic and cardiovascular disease markers high triglyceride concentration (p = 0.02 in men and p = 0.001 in women) and high apolipoprotein B/apolipoprotein A1 ratio (p = 0.04 in men and p = 0.03 in women) were independently associated with low 25OHD level. Conclusions Higher age did not predict lower 25OHD level in this study population of aged 45–74 years which may derive from a healthy life-style of “active pensioners”. Low physical activity and smoking came up as independent lifestyle factors associated with low 25OHD level. Defining the molecular mechanisms behind the associations of 25OHD with low physical activity and smoking are important objective in future studies. The association of 25OHD with BMI, high triglyceride concentration and apolipoprotein B/apolipoprotein A1 ratio may be related to the role of vitamin D in inflammation, but more detailed studies are needed.

[1]  R. Mason,et al.  Uptake of 25-hydroxyvitamin D by muscle and fat cells , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  B. Zinman,et al.  Prospective association of 25(OH)D with metabolic syndrome , 2014, Clinical endocrinology.

[3]  M. Holick,et al.  Vitamin D and inflammation , 2014, Dermato-endocrinology.

[4]  R. Mason,et al.  Evidence for a specific uptake and retention mechanism for 25-hydroxyvitamin D (25OHD) in skeletal muscle cells. , 2013, Endocrinology.

[5]  C. Sempos,et al.  Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES. , 2013, The Journal of clinical endocrinology and metabolism.

[6]  S. Bojesen,et al.  Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. , 2013, Clinical chemistry.

[7]  T. Spector,et al.  Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts , 2013, PLoS medicine.

[8]  T. Lehtimäki,et al.  Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk. , 2013, Atherosclerosis.

[9]  J. Gummert,et al.  Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review , 2013, European Journal of Nutrition.

[10]  S. Männistö,et al.  Vitamin D status is associated with sociodemographic factors, lifestyle and metabolic health , 2013, European Journal of Nutrition.

[11]  J. Brody.  Transcriptome alterations induced by cigarette smoke , 2012, International journal of cancer.

[12]  T. Tuomainen,et al.  Association of serum 25‐hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland , 2012, Diabetes/metabolism research and reviews.

[13]  R. Luben,et al.  Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies , 2012, Diabetologia.

[14]  I. Kema,et al.  Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l , 2012, British Journal of Nutrition.

[15]  R. Jorde,et al.  Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. , 2011, Progress in lipid research.

[16]  V. Montori,et al.  Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. , 2011, The Journal of clinical endocrinology and metabolism.

[17]  P. Fowler,et al.  Maternal smoking and fetal sex significantly affect metabolic enzyme expression in the human fetal liver. , 2011, The Journal of clinical endocrinology and metabolism.

[18]  D. Muzio,et al.  Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty-five years , 2011, The journal of nutrition, health & aging.

[19]  N. Saidenberg-Kermanac’h,et al.  Vitamin D and inflammation. , 2010, Joint, bone, spine : revue du rhumatisme.

[20]  J. Manson,et al.  Plasma 25-Hydroxyvitamin D Concentration and Risk of Incident Type 2 Diabetes in Women , 2010, Diabetes Care.

[21]  M. Sathe,et al.  Update in pediatrics: focus on fat-soluble vitamins. , 2010, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[22]  C. Mathieu,et al.  Vitamin D: modulator of the immune system. , 2010, Current opinion in pharmacology.

[23]  Sirkka Keinänen-Kiukaanniemi,et al.  Lifestyle Intervention for Prevention of Type 2 Diabetes in Primary Health Care , 2010, Diabetes Care.

[24]  E. Hyppönen,et al.  25-Hydroxyvitamin D and Pre-Clinical Alterations in Inflammatory and Hemostatic Markers: A Cross Sectional Analysis in the 1958 British Birth Cohort , 2010, PloS one.

[25]  E. Levy,et al.  Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents. , 2010, The Journal of nutrition.

[26]  R. Jorde,et al.  No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year , 2010, Journal of internal medicine.

[27]  R. Jorde,et al.  Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study , 2010, European journal of nutrition.

[28]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[29]  A. Frasheri,et al.  Small, dense low‐density lipoproteins (LDL) are predictors of cardio‐ and cerebro‐vascular events in subjects with the metabolic syndrome , 2009, Clinical endocrinology.

[30]  R. Heaney,et al.  Vitamin D3 Distribution and Status in the Body , 2009, Journal of the American College of Nutrition.

[31]  A. Hamsten,et al.  Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. , 2008, European heart journal.

[32]  L. Foo,et al.  Relationship between vitamin D status, body composition and physical exercise of adolescent girls in Beijing , 2009, Osteoporosis International.

[33]  R. Prassl,et al.  Molecular structure of low density lipoprotein: current status and future challenges , 2009, European Biophysics Journal.

[34]  A. Scanu,et al.  HDL: bridging past and present with a look at the future , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  B. Astor,et al.  25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.

[36]  Glenville Jones.  Pharmacokinetics of vitamin D toxicity. , 2008, The American journal of clinical nutrition.

[37]  T. Laitinen,et al.  Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. , 2008, Journal of the American College of Cardiology.

[38]  Steven Hawken,et al.  Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study , 2008, The Lancet.

[39]  E. Hyppönen,et al.  25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age , 2008, Diabetes.

[40]  S. Poppitt,et al.  Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity , 2008, Nutrition Journal.

[41]  P. Zimmet,et al.  Diagnosis and classification of diabetes mellitus , 2002 .

[42]  C. Inderjeeth,et al.  Vitamin D and muscle strength in patients with previous fractures. , 2007, The New Zealand medical journal.

[43]  A. Auvinen,et al.  An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. , 2007, The American journal of clinical nutrition.

[44]  D. Knol,et al.  Vitamin D status predicts physical performance and its decline in older persons. , 2007, The Journal of clinical endocrinology and metabolism.

[45]  V. Salomaa,et al.  Non-participation and mortality in different socioeconomic groups: the FINRISK population surveys in 1972–92 , 2007, Journal of Epidemiology and Community Health.

[46]  Sirkka Keinänen-Kiukaanniemi,et al.  National type 2 diabetes prevention programme in Finland: FIN-D2D , 2007, International journal of circumpolar health.

[47]  L. Clemson,et al.  Effects of diet and exercise on plasma vitamin D (25(OH)D) levels in Vietnamese immigrant elderly in Sydney, Australia , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[48]  B. Hollis,et al.  Low circulating vitamin D in obesity , 1988, Calcified Tissue International.

[49]  A. Shao,et al.  Risk assessment for vitamin D. , 2007, The American journal of clinical nutrition.

[50]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[51]  B. Boucher,et al.  Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis. , 2005, The American journal of clinical nutrition.

[52]  B. Boucher,et al.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. , 2004, The American journal of clinical nutrition.

[53]  B. Fagerberg,et al.  Apolipoprotein B/Apolipoprotein A-I in Relation to the Metabolic Syndrome and Change in Carotid Artery Intima-Media Thickness During 3 Years in Middle-Aged Men , 2004, Stroke.

[54]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[55]  H. Meltzer,et al.  Nordic Nutrition Recommendations 2004 – integrating nutrition and physical activity , 2004 .

[56]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[57]  L. Adorini,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.

[58]  N. Jørgensen,et al.  The influence of smoking on vitamin D status and calcium metabolism , 1999, European Journal of Clinical Nutrition.

[59]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[60]  L. Niskanen,et al.  Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. , 1997, European journal of endocrinology.

[61]  R. Scragg,et al.  Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. , 1992, Annals of epidemiology.

[62]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[63]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[64]  M. Holick,et al.  Aging decreases the capacity of human skin to produce vitamin D3. , 1985, The Journal of clinical investigation.

[65]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.